Interesting scientific research on 2213-63-0

One of the oldest and most widely used commercial enzyme inhibitors is aspirin, 2213-63-0, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 2213-63-0

New Advances in Chemical Research, May 2021. The prevalence of solvent effects in heterogeneous catalysis in condensed media has motivated developing theoretical assessments of solvent structures and their interactions with reaction intermediates. 2213-63-0, We’ll be discussing some of the latest developments in chemical about CAS: 2213-63-0, name is 2,3-Dichloroquinoxaline. In an article,Which mentioned a new discovery about 2213-63-0

The invention belongs to the field of drug synthesis, in particular relates to a one-pot process for preparing 2, 3 – dichloro quinoxaline derivatives of the new method, the method uses the low-O-phenylene diamine and oxalic acid as the raw material, cheap and easily obtained and environment-friendly silica gel or methanesulfonic acid as catalyst, at the same time omitting the intermediate separation and purification steps, the operation is simple, low cost, mild reaction conditions, and environmental protection, is easy for industrial production. (by machine translation)

One of the oldest and most widely used commercial enzyme inhibitors is aspirin, 2213-63-0, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 2213-63-0

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1149 | ChemSpider